These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 23477713

  • 1. S1. Rituximab for ANCA-associated vasculitis: the experience in the United States.
    Clain JM, Specks U.
    Presse Med; 2013 Apr; 42(4 Pt 2):530-2. PubMed ID: 23477713
    [No Abstract] [Full Text] [Related]

  • 2. S3. Rituximab for ANCA-associated vasculitides: the French experience.
    Charles P, Guillevin L.
    Presse Med; 2013 Apr; 42(4 Pt 2):534-6. PubMed ID: 23453207
    [No Abstract] [Full Text] [Related]

  • 3. L43. Seropositive and negative ANCA-associated vasculitis, anti-MPO and PR3-vasculitis: different outcomes?
    Holle JU.
    Presse Med; 2013 Apr; 42(4 Pt 2):616-9. PubMed ID: 23481358
    [No Abstract] [Full Text] [Related]

  • 4. [Development of morbidity and mortality in ANCA-associated vasculitis].
    Reinhold-Keller E, Moosig F.
    Z Rheumatol; 2011 Aug; 70(6):486-92. PubMed ID: 21779878
    [Abstract] [Full Text] [Related]

  • 5. L52. Vasculitis treatment: is it time to change the standard of care for ANCA-associated vasculitis?
    Hoffman GS.
    Presse Med; 2013 Apr; 42(4 Pt 2):643-50. PubMed ID: 23474045
    [No Abstract] [Full Text] [Related]

  • 6. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.
    Jones RB, Furuta S, Tervaert JW, Hauser T, Luqmani R, Morgan MD, Peh CA, Savage CO, Segelmark M, Tesar V, van Paassen P, Walsh M, Westman K, Jayne DR, European Vasculitis Society (EUVAS).
    Ann Rheum Dis; 2015 Jun; 74(6):1178-82. PubMed ID: 25739829
    [Abstract] [Full Text] [Related]

  • 7. L44. Management of relapses in vasculitis.
    Mouthon L.
    Presse Med; 2013 Apr; 42(4 Pt 2):619-22. PubMed ID: 23477710
    [No Abstract] [Full Text] [Related]

  • 8. Rituximab in ANCA-associated vasculitis: fad or fact?
    Fervenza FC.
    Nephron Clin Pract; 2011 Apr; 118(2):c182-8; discussion c188. PubMed ID: 21160229
    [Abstract] [Full Text] [Related]

  • 9. Current landscape of antineutrophil cytoplasmic antibody-associated vasculitis: classification, diagnosis, and treatment.
    Lally L, Spiera R.
    Rheum Dis Clin North Am; 2015 Apr; 41(1):1-19, vii. PubMed ID: 25399936
    [Abstract] [Full Text] [Related]

  • 10. S2. Rituximab for ANCA-associated vasculitis: the UK experience.
    Jayne D.
    Presse Med; 2013 Apr; 42(4 Pt 2):532-4. PubMed ID: 23490639
    [No Abstract] [Full Text] [Related]

  • 11. ANCA-negative ANCA-associated vasculitis: pitfalls of the 'vasculitis screen'.
    Cooke H, Wells M, Miller K, Medford ARL, Patel S.
    Clin Med (Lond); 2023 Nov; 23(6):630-632. PubMed ID: 38065599
    [Abstract] [Full Text] [Related]

  • 12. Treatment of antineutrophil cytoplasmic antibody-associated vasculitis: update.
    Santana AN, Woronik V, Halpern AS, Barbas CS.
    J Bras Pneumol; 2011 Nov; 37(6):809-16. PubMed ID: 22241040
    [Abstract] [Full Text] [Related]

  • 13. Rituximab for maintenance of remission in ANCA-associated vasculitis: expert consensus guidelines.
    Tieu J, Smith R, Basu N, Brogan P, D'Cruz D, Dhaun N, Flossmann O, Harper L, Jones RB, Lanyon PC, Luqmani RA, McAdoo SP, Mukhtyar C, Pearce FA, Pusey CD, Robson JC, Salama AD, Smyth L, Watts RA, Willcocks LC, Jayne DRW.
    Rheumatology (Oxford); 2020 Apr 01; 59(4):e24-e32. PubMed ID: 32096545
    [No Abstract] [Full Text] [Related]

  • 14. [Treatment of ANCA-associated vascularitides].
    Guillevin L, Pagnoux C.
    Presse Med; 2007 May 01; 36(5 Pt 2):922-7. PubMed ID: 17408912
    [Abstract] [Full Text] [Related]

  • 15. L39. Fulminant ANCA vasculitis.
    Karras A, Jacquot C, Thervet E.
    Presse Med; 2013 Apr 01; 42(4 Pt 2):607-9. PubMed ID: 23453211
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. L25. Medical treatment of subglottic stenosis in granulomatosis with polyangiitis (Wegener's).
    Monach PA.
    Presse Med; 2013 Apr 01; 42(4 Pt 2):575-6. PubMed ID: 23453209
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of antineutrophil cytoplasmic antibody-associated vasculitis.
    Rich EN, Brown KK.
    Curr Opin Pulm Med; 2012 Sep 01; 18(5):447-54. PubMed ID: 22854508
    [Abstract] [Full Text] [Related]

  • 20. Biological therapies: new treatment options for ANCA-associated vasculitis?
    Aries PM, Lamprecht P, Gross WL.
    Expert Opin Biol Ther; 2007 Apr 01; 7(4):521-33. PubMed ID: 17373903
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.